Back to results
US 2026/0061033 A1Published application
Il-15-based molecules and methods of use thereof
AssigneeAltor BioScience Corporation
InventorsBai Liu, Peter Rhode, Wenxin Xu, Hing C. Wong
Life of this patent
Estimating the term…
Abstract
The invention features combination therapies using an IL-15-based superagonist complex and an antibody to effectively treat subjects with cancer and infectious diseases.
Claims21
-30. (canceled)
A method of treatment for cancer in a human subject, the method comprising administering to the subject:
- (a) a therapeutically effective amount of an anti-Ganglioside GD2 antibody;
- and
- (b) a therapeutically effective amount of an IL-15N72D:IL-15RαSu/Fc complex comprised of a dimeric IL-15RαSu/Fc molecule and two IL-15N72D molecules.
Dependencies are inferred from the claim text.